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Abstract
Background
Psychotic experiences (PE) may co-occur with common mental disorders (CMD), such as 
depression and anxiety. However, we know very little about the prevalence of and recovery 
from PE in primary mental health care settings, such as the Improving Access to 
Psychological Therapies (IAPT) services in the UK National Health Service (NHS), where 
most CMD are treated. 
Methods
We used the Community Assessment of Psychic Experiences - Positive 15-item Scale 
(CAPE-P15) to determine the prevalence of PE in patients receiving treatment from IAPT 
services. Patient-reported measures of depression (PHQ-9) and anxiety (GAD-7) are 
routinely collected and establish recovery in IAPT services. We studied recovery rates 
according to the absence and presence of PE. Multi-group growth models estimated 
improvement trajectories for each group.
Results
2,042 patients with CMD completed the CAPE-P15. The mean age was 39.8. The overall 
prevalence of PE was 29.68%. The recovery rate was 27.43% compared to 62.08% for those 
without PE. Although patients with or without PE shared similar improvement trajectories, 
the initial severity of patients with PE impeded their likelihood of recovery.
Limitations
We mirrored routine data collection in IAPT services, including self-report questionnaires 
that may affect valid reporting of symptoms. Missing data in the calculation of improvement 
trajectories may reduce generalisability. 
2
Conclusions 
At least one in four patients receiving treatment from IAPT services in primary care 
experience CMD and PE. This significant group of people experience a lower recovery rate, 
with adverse implications not only for them but also for efficiency of services.
Keywords




Psychotic experiences (PE) such as attenuated paranoid beliefs or voice hallucinations are 
relatively common in the general population, especially amongst young people (Linscott and 
van Os, 2013). Systematic reviews and evidence synthesis indicate that, viewed from a 
secondary-care perspective, approximately one third of people with at risk mental states for 
psychosis, mostly characterised by intense and frequent attenuated psychotic symptoms, will 
transition to a psychotic disorder (Fusar-Poli et al., 2012; Addington et al. 2011). Research in 
non-specialised services, such as primary care settings, has shown that far fewer (~10%) 
make such a conversion (Hui et al. 2013; Perez et al. 2017). 
PE predict propensity to seek treatment from mental health services (DeVylder et al., 
2014) and are also linked to the presence of other, non-psychotic common mental disorders 
(CMD), particularly depression and anxiety (Wigman et al., 2012; Hui et al., 2013). 
Population studies of adolescents and young people modelling the co-occurrence of 
depression, anxiety and PE have found that all three shared an underlying unitary 
psychopathological factor, i.e. common mental distress, with PE emerging towards its more 
severe end (Stochl et al., 2015). Thus, PE may not only act as a specific risk factor for 
developing psychosis; they may also act as a maker for mental ill-health more generally, 
indicating clinical severity and increased likelihood of co-morbidity, suicidality and poorer 
treatment outcomes (Healy et al., 2019; Yates et al., 2019; Cederlöf at al., 2018; Hui et al. 
2013; Kelleher et al. 2012; Perez et al. 2017; Wigman et al. 2014).
Research examining the impact of PE has predominantly been conducted in 
specialised secondary mental health services designed to support those with an at-risk mental 
state (Wigman et al, 2012; Lin et al, 2015), or, conversely, in population samples (Varghese 
et al., 2011).  Much less is known about the prevalence and impact of PE in primary mental 
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healthcare services, where most CMD are treated. One example of primary mental health care
in England is the Improving Access to Psychological Therapies (IAPT) Programme 
(https://www.england.nhs.uk/mental-health/adults/iapt/). The IAPT programme was designed
to make evidence-based psychological therapies for mild to moderate depression and anxiety 
disorders, collectively termed CMD, more widely available in the National Health Service 
(NHS) in England. 
Although IAPT is commissioned to deliver talking therapies for mild to moderate 
CMD, they serve a clinical population with increasingly complex and co-morbid conditions 
(Hepgul et al., 2016; Buckman et al., 2018; Goddard et al., 2015). Given the co-occurrence of
PE with depression and anxiety, and evidence that PE index severity in these disorders 
(Stochl et al., 2015), it is reasonable to hypothesise that a proportion of IAPT patients will 
experience psychotic phenomena. 
Currently, the IAPT programme neither screens for, nor offers specific treatment for 
PE. Treatment protocols that focus exclusively on mood disturbance, leaving PE undetected 
and untreated may potentially exacerbate depression and anxiety. Such complexity and co-
morbidity suggest that a significant minority of patients in IAPT services would be managed 
sub-optimally by the standard interventions for CMD the services are designed to deliver. 
To understand the potential prevalence and impact of PE on meeting service-level 
thresholds defining recovery from depression and anxiety in IAPT services, we conducted an 
exploratory evaluation in two IAPT teams in Cambridgeshire and Peterborough NHS 
Foundation Trust (Perez et al., 2017) using the current, 15-item version of the Community 
Assessment of Psychic Experiences (CAPE-P15; Capra et al., 2017). Results revealed that a 
higher prevalence of PEs was associated with higher depression and anxiety scores both at 
therapy outset and during the initial period of therapy. This period is considered a predictor of
potential full recovery in the IAPT setting (Delgadillo et al., 2014). 
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This evaluation was the first to measure PE in the IAPT population and suggested that
a significant proportion of patients accessing IAPT services experience CMD including PEs 
(CMD-P), and are less likely to recover following therapy. However, this study was limited 
both in sample size and diversity, reducing the applicability of the findings to larger and more
diverse IAPT populations. In addition, the statistical technique applied in this study was 
latent class analysis which categorised individuals as experiencing CMD-PE based on the 
probability of responses; therefore, a 30% prevalence of CMD-P may be an over-estimation. 
Furthermore, estimations of recovery were based on the response to the initial period of 
therapy rather than on recovery rates calculated as per national IAPT reporting at the end of 
therapy (Health and Social Care Information Centre: 
https://www.nhs.uk/Scorecard/Pages/IndicatorFacts.aspx?MetricId=6228). The current study 
aimed to address these limitations by 1) replicating data collection on a larger and more 
diverse population treated within the IAPT programme, 2) using recently established CAPE-
P15 cut-off thresholds to detect PE in primary care (Bukenaite et al., 2017), and 3) comparing
recovery rates between patients with CMD including PE and those without such experiences 
at the end of therapy in IAPT services.
Methods
Setting
The IAPT programme in England began in 2008 with a direct objective to improve access to 
evidence-based psychological treatment for CMD. It aimed to increase public access to 
National Institute for Health and Care Excellence (NICE) approved psychological therapies 
by offering flexible referral routes including self-referral and defining care pathways via a 
stepped care model. The programme has continued to expand over time and currently 
assesses over 1,300,000 people with CMD annually, delivering therapy to approximately 
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550,000. NHS England has committed to further expansion of the programme, aiming to see 
1.9 million patients annually by 2024 (Clark, 2019). IAPT provides treatment for CMD for 
people aged 17-65 years. Cognitive–behavioural therapy (CBT) is the predominant approach 
adopted by these services, although there is a wider range of recommended treatments (e.g. 
counselling, couples therapy, interpersonal therapy or brief psychodynamic) particularly for 
depression. The number of sessions can vary between 8 and 20, although patients with more 
severe CMD receive an average of 12 over a period of 3-4 months. 
Measures
The IAPT programme stipulates a minimum dataset, which records the clinical care offered 
to each patient and their clinical progress, via patient-reported outcome measures of 
depression and anxiety, i.e. The Patient Health Questionnaire (PHQ-9) (Kroenke,
Spitzer, & Williams, 2001) and Generalized Anxiety Disorder questionnaire (GAD-7) 
(Spitzer, Kroenke, Williams, & Löwe, 2006). These measures are completed during triage, 
assessment and at each subsequent treatment session, ensuring that each patient has a clinical 
endpoint, even if they leave treatment unexpectedly. Services store this data using one of two 
patient management systems (PCMIS: https://www.york.ac.uk/healthsciences/pc-mis/ or 
IAPTUS: https://iaptus.co.uk/) and use the information to establish recovery from depression 
and anxiety. Several improvement metrics are used, including the recovery index (Gyani et 
al., 2013). This states that a patient has recovered if they score above the clinical cut-off on 
PHQ-9 and/or GAD-7 at outset of treatment, and below the cut-off for both the PHQ-9 and 
GAD-7 post-treatment, i.e. below 10 and 8 respectively. Nationally, 51% of patients 
accessing IAPT recover (Clark et al, 2018), although outcomes vary significantly across 
England. Reasons for such variation have been attributed to organisational factors such as 
waiting times, social deprivation, fidelity to a therapeutic model, dose responses effects and 
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variation in the clinical complexity of patients seen across services (Clark et al. 2018; Gyani 
et al. 2013 Delgadillo et al. 2014).
Our participating IAPT services also collected the current CAPE-P15. This is 15-item 
self-report measure of experiences similar to positive psychotic symptoms, grouped into three
dimensions; “delusional ideation”, “bizarre experiences” and “perceptual abnormalities” (See
Table 1) and experienced within the past three months. It includes two 4-point Likert scales: 
one to indicate frequency and one to indicate distress associated with the experience. It 
provides a mean per-item score on both subscales, with higher scores indicating a higher 
frequency of PE and an increased level of distress associated with these experiences (Capra et
al., 2013). Previous work (Bukenaite et al., 2017) recommended a cut-off of 1.47 for both 
subscales of the CAPE-P15 in order to identify clinically significant PE. This cut-off was 
calibrated against the Comprehensive Assessment of At-Risk States (CAARMS) (Yung et al.,
2005) which identifies individuals with at-risk mental states for psychosis (ARMS). The 
feasibility and acceptability of this self-report questionnaire to identify these individuals in 
IAPT settings have already been confirmed (Perez et al., 2017).
-- Table 1 about here –
Sample
The analysis was conducted on a sample of patients who were eligible for treatment under the
Improving Access to Psychological Therapies (IAPT) programme across three mental health 
Trusts in England: Cambridgeshire and Peterborough NHS Foundation Trust (CPFT), 
Norfolk and Suffolk NHS Foundation Trust (NSFT) and Sussex Partnership NHS Foundation
Trust (SPFT). Services in these trusts cover a wide and heterogeneous geographical area with 
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a total population of more than 4 million people living in diverse socioeconomic conditions, 
including urban, suburban and highly dispersed rural communities such as Fenland. Of 321 
English local authority districts, those involved range from most deprived (Hastings, Sussex) 
to least deprived (South Cambridgeshire, Cambridgeshire) (https://www.gov.uk/government/
statistics/english-indices-of-deprivation-2019).
Data from the entire IAPT caseload of each Trust receiving services between 
February and December 2018 were included in analysis. For calculation of prevalence, the 
caseload was defined as all patients receiving treatment between the commencement and end 
of CAPE-P15 collection (February – December 2018). Regardless of when each patient 
completed the CAPE-P15, we obtained recovery data from their initial session up until their 
end of care date.
All patients who were accepted for treatment under the IAPT programme across the 
three participating mental health Trusts were eligible to complete the CAPE-P15 
questionnaire. IAPT therapists in CPFT and SPFT offered the CAPE-P15 to patients during a 
treatment session or to complete at home between sessions. NSFT collect all routine clinical 
data remotely using a digital portal, links to which are automatically sent out to patients by 
the service. Patients were informed that completing the CAPE-P15 was voluntary. 
Participants were only required to complete a CAPE-P15 once during a course of therapy, at 
any time point determined appropriate by the therapist. It was accompanied by a short 
explanation of the evaluation and instructions for completion. 
This study was approved by and registered with the official NHS Quality 
Improvement Programmes of all participating mental health NHS trusts, and confirmed as 
such by the UK Health Research Authority (https://www.hra.nhs.uk/). Data analysis followed
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the guidelines established by the UK Anonymisation Standard for Publishing Health and 
Social Care Data (https://digital.nhs.uk/).
Statistical Analysis 
We compared sociodemographic information between patients who completed a CAPE-P15, 
and those who did not. Comparisons were made using t-test for continuous variables and chi-
square test for categorical variables. 
Prevalence and recovery rates are presented separately for CAPE-P15 positive and 
negative patients, as determined by the cut-off of 1.47 for both subscales of the CAPE-P15 
(See Measures, above). The service caseload comprises patients who had at least two 
treatment sessions (excluding triage sessions) with the IAPT service and at least one 
appointment after completing a CAPE-P15. Recovery rates were calculated for patients who 
had been discharged from the service and had at least one appointment after completing a 
CAPE-P15, using the recovery index (Gyani et al., 2013). 
Multigroup growth modelling (where groups were CAPE-P15 positive and negative 
patients) estimated improvement trajectories for each group. This modelling approach fits a 
non-linear trend to the repeated measures of outcomes (total scores of PHQ-9 and GAD-7 
over the course of therapy) for each patient. A subsample of n=1,149 patients from CPFT and
SPFT were used in this analysis as required information on appointment number was not 




Two thousand and forty-two CAPE-P15s were collected from 28, 852 patients receiving 
IAPT treatment during the data collection period; this was 7% of the caseload.  
Participant sociodemographic characteristics
Table 2 provides a comparison of age, sex and ethnicity for patients who did and did not 
complete a CAPE-P15.
As the sample was a proportion of the caseload, analyses were conducted to ascertain any 
differences between patients who did and did not complete a CAPE-P15. The mean age of 
patients who completed a CAPE-P15 was 39.8 (SD=15.34) and 39.2 (SD=15.25) for patients 
who did not complete a CAPE-P15. There was no significant difference in age between 
patients who did and did not complete a CAPE-P15 (t = 1.8127, df = 2351.1, p = 0.07). A 
higher percentage (68.9%) of women completed the CAPE-P15 than men (31%).  However, 
this sex difference was not significant when comparing the patients who did and did not 
complete a CAPE-P15 (X2 = 1.0206, df = 1, p = 0.3124). Table 2 reveals that the majority of 
patients in this IAPT sample were white. The difference in ethnicity between the patients who
did and did not complete a CAPE-P15 was not significant (X2 = 12.225, df = 6, p = 0.06).
-- Table 2 about here –
Prevalence of psychotic experiences 
Table 3 shows the number of CAPE-P15 assessments collected from patients receiving 
treatment in an IAPT in the 3 mental health trusts. The prevalence of CAPE-P15 positive 
patients was between 22 and 35 percent. 
-- Table 3 about here --
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Recovery rates 
Table 4 compares the rates of recovery between CAPE-P15 positive and negative patients. 
This demonstrates that the recovery rates for CAPE-P15 negative patients fall within the 
nationally reported range for recovery in the 3 participating trusts. The percentage of patients 
reaching recovery at discharge was noticeably lower for CAPE-P15 positive patients (21% - 
39%) across all 3 trusts when compared to CAPE-P15 negative patients (48% - 71%). 
-- Table 4 about here –
Improvement trajectories 
Figure 1 provides the mean improvement trajectories for CAPE-P15 positive and negative 
patients for both PHQ-9 and GAD-7. The initial severity for CAPE positive patients was 
much higher than for CAPE negative patients for both PHQ-9 and GAD-7, with CAPE-P15 
positive patients on average beginning therapy with scores of 17.5 and 15.5 compared to 
CAPE- P15 negative patients who entered treatment with scores of approximately 13 and 12 
on PHQ-9 and GAD-7 respectively.
Interestingly, the improvement rates (trajectory slopes) are similar for both groups. However, 
patients with PE require many more sessions to reach the threshold for recovery (on average) 
compared to those without. The difference between CAPE-P15 positive and negative patients
in mean number of appointments required to reach recovery was greater for PHQ-9 than for 
GAD-7. CAPE-P15 negative patients required on average 6 sessions compared to 17 sessions
for CAPE-P15 positive patients to reach recovery on PHQ-9. On GAD-7, CAPE-P15 
negative patients required 10 sessions to reach recovery; CAPE-P15 positive patients did not 
reach recovery at 20 sessions. 
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--Figure 1 about here--
Discussion
Our study confirmed the results of a previous, exploratory evaluation (Perez et al., 2017), 
demonstrating the presence of PE in an IAPT sample. It also established that patients with 
CMD-P were less likely to recover by the end of treatment. 
Using a cut-off score of 1.47 on the CAPE-P15, indicative of symptom severity 
comparable to those observed in individuals at risk of developing psychosis (Bukenaite et al., 
2017), this study found that approximately 1 in 4 patients receiving IAPT treatment reported 
PE. Of these patients, only a third had recovered by the end of treatment. 
Patients with depression and/or anxiety with the presence of PE began their course of 
treatment with IAPT with higher scores on both the PHQ-9 and GAD-7 measures, confirming
that this group of patients enter the service with more severe symptoms of CMD. Although 
this group of patients showed a reduction in their depression and anxiety scores across 
sessions, their improvement trajectories were insufficiently steep to reach recovery, even 
after receiving twice the number of sessions that were necessary for recovery in patients 
without PE. 
IAPT services are limited in terms of the number of sessions; the number offered 
varies between eight and twenty depending on the service, treatment modality and presenting 
problem (The National Collaborating Centre for Mental Health, 2018). Therefore, simply 
increasing the total number of sessions for patients with PE until they reach recovery is not 
feasible within the remit of the service. Given that initial symptom severity predicts the 
likelihood of recovery, with more severe patients needing greater improvements to drop 
below the caseness threshold than those with moderate symptomology, recovery over a 
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limited number of sessions may appear unobtainable. However, evidence suggests that 
patients with more severe symptoms may benefit more from therapy than those with 
moderate or mild symptoms. In a sample of IAPT patients, analysis of mean change scores 
showed the greatest improvements were found in patients entering therapy with higher scores
(Gyani et al. 2013).
To be effective, treatments with this group of patients would need to deliver a steeper 
improvement trajectory to maximise improvement in symptoms pre- and post-therapy. 
Currently, IAPT services do not routinely measure PE or offer specific treatment for patients 
who have them in addition to depression and anxiety. Therefore, the specific therapeutic 
approaches needed to treat this large but under-served group are missing. Effective NICE 
recommended psychological treatments for patients with depression and anxiety with PE do 
exist but are not currently included in IAPT treatment protocols.  Examples include CBT for 
at-risk mental states (French & Morrison, 2004), a cognitive-behavioural therapy which can 
effectively delay and prevent the transition to a first episode of psychosis (van der Gaag et al.,
2019). Whilst individuals with a psychotic disorder interpret their symptoms as reality, those 
with an at-risk mental state experience less delusional certainty and are receptive to multiple 
explanations for their symptoms. CBT for this group aims to normalise unusual experiences 
and generate non-delusional interpretations of such experiences using psychoeducation, 
whilst preventing the consolidation of delusional beliefs by circumventing avoidance 
behaviours. 
Co-morbidity with depression and anxiety is common amongst patients with an at-risk
mental state, possibly related to delusional uncertainty where symptoms are understood as 
perceptual abnormalities rather than reality; simply put, the fear of losing one’s mind. 
However, CBT for ARMS places prevention of transition to psychosis as the primary 
outcome, with a consequent reduction in depression and anxiety. To be eligible for treatment 
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in IAPT services, the presenting difficulty for a patient must be either depression, anxiety or a
stress-related disorder, and recovery is based on indices of depression and anxiety. Treatment
therefore must focus on these disorders; patients in IAPT with PE will likely have treatment 
goals closely aligned to their CMD but focusing on mood disturbance alone leaves PE 
untreated and potentially exacerbates depression and anxiety. 
This study represents an important work stream of a wider, innovative UK National 
Institute for Health Research (NIHR) Programme Grant for Applied Research (TYPPEX;  
https://www.nihr.ac.uk/news/innovative-mental-health-study-launches-in-eastern-region/
6931), where we propose that by reconfiguring existing treatment protocols for both CMD 
and at-risk mental states, prospects for recovery in these patients could be greatly improved. 
Identifying PE, understanding how they contribute to a patient’s clinical presentation and 
integrating techniques into existing IAPT CBT treatment would provide a tailored therapy 
that would better meet individual needs and address CMD-P, rather than treating individual 
difficulties in isolation. Drawing on the existing skills of trained CBT therapists in IAPT and 
upskilling them with techniques to address PE would allow treatment to be tailored to the 
individual and assist the therapist to work with complex presentations and multiple symptoms
in a systematic manner.
Limitations
Despite the originality of this study and the knowledge it adds to the literature about the 
prevalence of PE and impact of PE on recovery rates in primary mental health services, 
several limitations should be considered when interpreting the findings.  First, the 
administering of the CAPE-P15 was not mandatory. This resulted in CAPE-P15 data being 
obtained for a limited proportion of the caseload. In addition, in CPFT and SPFT therapists 
could exercise discretion when asking patients to complete a CAPE-P15. However, in NSFT 
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the CAPE-P15 was automatically distributed to new patients via email, eliminating selection 
bias at this site. A concern was that therapists in CPFT and SPFT selected more complex 
patients in order to help with an understanding of the patient’s presentation, potentially 
inflating the prevalence of PE in these services’ caseloads. However, the highest prevalence 
was observed in NSFT where the CAPE-P15 was distributed electronically to all new patients
during the collection period (see Table 3).  Recovery outcomes were similar across all three 
sites. In addition, no basic sociodemographic difference was found between those who 
completed the CAPE-P15 and those who did not across sites.  Second, the over and under 
reporting of symptoms using self-report questionnaires is well documented. Using a self-
report instrument to measure PE could overestimate the prevalence because, unlike semi-
structured interviews or clinical assessments, they do not allow for questioning to ensure that 
the experiences described are valid and questions have not been misunderstood. Differences 
between the prevalence of psychotic experiences measured by semi-structured interviews and
self-reported experiences have been as high as 55% (5% & 60% respectively (Zammit et al., 
2013). Conversely, social desirability and stigma may prevent patients from reporting PE. 
Nonetheless, prior evidence supports the validity of the CAPE-P15 to measure PE accurately 
(Mark & Toulopoulou, 2016; Núñez et al., 2015). Third, the estimated improvement 
trajectories were calculated for CPFT and SFPT only, as crucial information (appointment 
number) needed for the calculation was missing from the NSFT data. Finally, the 1.47 cut-off
threshold was calculated using a measure which identifies an ARMS population (Bukenaite et
al., 2017); therefore it may be too high to identify all patients with CMD and PE accessing 
primary care. Increasing the CAPE-P15’s sensitivity by reducing this threshold might capture
those experiencing fewer and/or less intense PE but higher CMD severity and, therefore, 
prone to poorer outcomes (Stochl et al. 2015). Future research should investigate whether 
increasing the sensitivity of the CAPE-P15 may offer a useful choice of cut-off values to 
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identify more people with PE and facilitate prompt access to more specific, evidence-based 
interventions.
Conclusion
At least 1 in 4 patients receiving treatment from IAPT services may suffer from PE in 
addition to CMD. This group of patients enter therapy with a more severe episode of CMD 
and are much less likely to recover by the end of treatment. Although improvement 
trajectories for this group showed improvement over sessions, remittance of symptoms was 
insufficient to meet national standards of IAPT recovery. We conclude that current 
psychological interventions in this service configuration are limited in their effectiveness 
with those population experiencing PE and CMD. 
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Table 1. The current CAPE-P15 – 15 questions, three subscales
†All questions ‘In the past 3 months, have you .. . .’
25
Subscales Questions
Persecutory ideation 1. . . . felt as if people seem to drop hints about you or say things with a double meaning?†
2. . . . felt as if some people are not what they seem to be?
3. . . . felt that you are being persecuted in anyway?
4. . . . felt as if there is a conspiracy against you?
5. . . . felt that people look at you oddly because of your appearance?
Bizarre experiences 6. . . . felt as if electrical devices such as computers can influence the way you think?
7. . . . felt as if the thoughts in your head are being taken away from you?
8. . . . felt as if the thoughts in your head are not your own?
9. . . . ever been so vivid that you were worried other people would hear them?
10. . . . heard your thoughts being echoed back at you?
11. . . . felt as if you are under the control of some force or power other than yourself?
12. . . . felt as if a double has taken the place of a family member, friend or acquaintance?
Perceptual abnormalities 13. . . . heard voices when you are alone?
14. . . . heard voiced talking to each other when you are alone?
15. . . . seen objects, people or animals that other people can’t see?
Table 2.  Comparison of age, sex and ethnicity for patients who did and did not complete a 
CAPE-P15. 
CAPE-P15 Status Positive % Negative % None % 
Age 17 6.4 2.8 2.7
18 – 35 47.8 38.8 46.3
36 – 64 44.1 50.8 44.4
65+ 1.7 7.6 6.6
Sex Male 29.2 32.5 32.2
Female 70.8 67.5 67.8
Ethnicity Asian/Asian British 1.8 1.4 1.4
Black/African/Caribbean/Black British 0.8 0.8 0.7
Mixed/Multiple ethnic groups 1.8 0.7 1.4
Mixed Other 0.8 0.2 0.4
Not stated/not known 8.8 6.4 6.2
Other ethnic group 0.8 0.3 0.5






CAPE-P15 positive CAPE-P15  negative
CPFT 590 22.5% (133) 77.5% (457)
NSFT 1073 34.8% (373) 65.2% (700)
SPFT 379 26.4% (100) 73.6% (279)
All sites 2042 29.7% (606) 70.3% (1436)
Table 3.  Prevalence of psychotic experiences across the three IAPT services.
Table 4.  Recovery rates for patients with and without psychotic experiences across the three 
IAPT services.
Site Status at discharge CAPE-P15 positive CAPE-P15 negative
CPFT
Not recovered 68.8% (77)   39.3%(132)   
Recovered 31.2% (35)     60.7% (204)    
NSFT
Not recovered 78.9% (131) 51.8% (129)
Recovered 21.1% (35) 48.2% (120)
SPFT
Not recovered 61.4% (43) 29.1% (50)
Recovered 38.6% (27) 70.9% (122)
All sites
Not recovered 72.1% (251) 41.1 (311)
Recovered 27.9% (97) 58.9 (446)
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Figure 1.  Trajectories of improvement for patients with and without psychotic experiences 
for PHQ-9 and GAD-7 
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